119 related articles for article (PubMed ID: 23140296)
1. DIMming ovarian cancer growth.
Kandala PK; Srivastava SK
Curr Drug Targets; 2012 Dec; 13(14):1869-75. PubMed ID: 23140296
[TBL] [Abstract][Full Text] [Related]
2. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
Zou M; Zhang X; Xu C
Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo.
Kandala PK; Srivastava SK
Drug Discov Ther; 2012 Apr; 6(2):94-101. PubMed ID: 22622019
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human ovarian cancer cell lines by devil's club Oplopanax horridus.
Tai J; Cheung S; Chan E; Hasman D
J Ethnopharmacol; 2010 Feb; 127(2):478-85. PubMed ID: 19835944
[TBL] [Abstract][Full Text] [Related]
5. Blocking epidermal growth factor receptor activation by 3,3'-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo.
Kandala PK; Wright SE; Srivastava SK
J Pharmacol Exp Ther; 2012 Apr; 341(1):24-32. PubMed ID: 22205686
[TBL] [Abstract][Full Text] [Related]
6. Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3).
Kandala PK; Srivastava SK
BMC Med; 2012 Jan; 10():9. PubMed ID: 22280969
[TBL] [Abstract][Full Text] [Related]
7. 3,3'-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy.
Ye Y; Fang Y; Xu W; Wang Q; Zhou J; Lu R
Biochem Pharmacol; 2016 Sep; 115():77-84. PubMed ID: 27372603
[TBL] [Abstract][Full Text] [Related]
8. Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo.
Kandala PK; Srivastava SK
J Biol Chem; 2012 Aug; 287(34):28745-54. PubMed ID: 22773833
[TBL] [Abstract][Full Text] [Related]
9. Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatment.
Zheng GF; Cai Z; Meng XK; Zhang Y; Zhu W; Pang XY; Dou L
Int J Clin Exp Pathol; 2015; 8(6):6505-11. PubMed ID: 26261528
[TBL] [Abstract][Full Text] [Related]
10. Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal Cancer.
Kim SM
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447608
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive effects of synthetic C-substituted diindolylmethanes originating from cruciferous vegetables in human oral cancer cells.
Shin JA; Shim JH; Choi ES; Leem DH; Kwon KH; Lee SO; Safe S; Cho NP; Cho SD
Eur J Cancer Prev; 2011 Sep; 20(5):417-25. PubMed ID: 21597379
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.
Banerjee S; Kong D; Wang Z; Bao B; Hillman GG; Sarkar FH
Mutat Res; 2011; 728(1-2):47-66. PubMed ID: 21703360
[TBL] [Abstract][Full Text] [Related]
13. Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK.
Kandala PK; Srivastava SK
Oncotarget; 2012 Apr; 3(4):435-49. PubMed ID: 22564965
[TBL] [Abstract][Full Text] [Related]
14. 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer.
Garikapaty VP; Ashok BT; Tadi K; Mittelman A; Tiwari RK
Biochem Biophys Res Commun; 2006 Feb; 340(2):718-25. PubMed ID: 16380095
[TBL] [Abstract][Full Text] [Related]
15. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
16. 3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease.
Tadi K; Chang Y; Ashok BT; Chen Y; Moscatello A; Schaefer SD; Schantz SP; Policastro AJ; Geliebter J; Tiwari RK
Biochem Biophys Res Commun; 2005 Nov; 337(3):1019-25. PubMed ID: 16219298
[TBL] [Abstract][Full Text] [Related]
17. Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft model.
Draz H; Goldberg AA; Tomlinson Guns ES; Fazli L; Safe S; Sanderson JT
Invest New Drugs; 2018 Aug; 36(4):718-725. PubMed ID: 29607466
[TBL] [Abstract][Full Text] [Related]
18. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways.
Lei P; Abdelrahim M; Safe S
Mol Cancer Ther; 2006 Sep; 5(9):2324-36. PubMed ID: 16985067
[TBL] [Abstract][Full Text] [Related]
19. Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells.
Kandala PK; Srivastava SK
Mol Pharmacol; 2010 Aug; 78(2):297-309. PubMed ID: 20444961
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3'-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis.
Hajra S; Basu A; Singha Roy S; Patra AR; Bhattacharya S
Free Radic Res; 2017 Oct; 51(9-10):812-827. PubMed ID: 28922986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
